论文部分内容阅读
目的分析探讨匹多莫德口服液在预防和治疗儿童反复呼吸道感染中的临床效果。方法选取120例反复呼吸道感染儿童患者作为临床研究对象,随机分为观察组和对照组,每组各60例。对照组患者给予常规抗感染治疗,观察组患者在常规治疗的基础上加用匹多莫德口服液进行治疗。比较两组患者的治疗效果。结果经过不同方式的治疗之后,在治疗效果方面,观察组患者发热、咳嗽、咽痛的时间分别为(2.01±0.55)、(6.08±1.44)和(5.65±1.52)d,明显少于对照组[分别为(2.74±0.62)、(7.63±1.67)和(6.95±1.68)d],差异均有统计学意义;同时,在预防效果方面,观察组患者的疾病复发率(16.67%)明显低于对照组(35.00%),差异有统计学意义(P<0.05)。结论匹多莫德口服液在预防和治疗儿童反复呼吸道感染中具有良好的效果,值得推广使用。
Objective To investigate the clinical effect of Pidotimod in the prevention and treatment of recurrent respiratory tract infections in children. Methods 120 cases of children with recurrent respiratory tract infection were selected as clinical study subjects and randomly divided into observation group and control group, 60 cases in each group. Patients in the control group were given conventional anti-infective therapy. Patients in the observation group were treated with pidotimod oral solution on the basis of routine treatment. The treatment effect of two groups of patients was compared. Results After treatment, the duration of fever, cough and sore throat in the observation group were (2.01 ± 0.55), (6.08 ± 1.44) and (5.65 ± 1.52) days, respectively, which were significantly lower than those in the control group [(2.74 ± 0.62), (7.63 ± 1.67) and (6.95 ± 1.68) d, respectively, with statistical significance; at the same time, the disease recurrence rate (16.67%) in observation group was significantly lower in prevention effect In the control group (35.00%), the difference was statistically significant (P <0.05). Conclusion Pidotimod oral solution in the prevention and treatment of recurrent respiratory tract infections in children with good results, it is worth promoting the use of.